Primary lymphoma of the liver: Clinical-pathological features and relationship with HCV infection in French patients

Hepatology

Volumn 37, Issue 4, 2003, Pages 781-787

  Bronowicki, Jean Pierre ^a,b   Bineau, Catherine ^a   Feugier, Pierre ^b   Hennine, Olivier ^c   Brousse, Nicole ^c   Oberti, Frédéric ^d   Rousselet, Marie Christine ^e   Dharancy, Sébastien ^f   Gaulard, Philippe ^g   Flejou, Jean François ^h   Cazals Hatem, Dominique ⁱ   Labouyrie, Eric ^b  

^a INSERM   (France)

^b UNIVERSITY HOSPITAL OF NANCY   (France)

^c HÔPITAL NECKER ENFANTS MALADES   (France)

^d Dept of Hepato Gastroenterologie ^*  (France)

^e ANGERS UNIVERSITY HOSPITAL   (France)

^f LILLE UNIVERSITY HOSPITAL   (France)

^g HENRI MONDOR HOSPITAL   (France)

^h HÔPITAL SAINT ANTOINE   (France)

ⁱ BEAUJON HOSPITAL   (France)

Author keywords

[No Author keywords available]

Indexed keywords

ANTIBODY; VIRUS RNA;

ADULT; AGED; ARTICLE; B CELL LYMPHOMA; BLOOD SAMPLING; BURKITT LYMPHOMA; CLINICAL ARTICLE; CLINICAL FEATURE; CONTROLLED STUDY; FEMALE; FRANCE; HEPATITIS C; HEPATITIS C VIRUS; HISTOPATHOLOGY; HUMAN; HUMAN TISSUE; IMMUNOCOMPETENCE; LIVER BIOPSY; LIVER CARCINOMA; MALE; PREVALENCE; PRIORITY JOURNAL; RETROSPECTIVE STUDY; REVERSE TRANSCRIPTION POLYMERASE CHAIN REACTION; T CELL LYMPHOMA;

EID: 0037381589     PISSN: 02709139     EISSN: None     Source Type: Journal    
DOI: 10.1053/jhep.2003.50121     Document Type: Article

References (47)

1. Zignego AL, Macchia D, Monti M, Thiers V, Mazzetti M, Foschi M, Maggi E, et al. Infection of peripheral mononuclear blood cells by hepatitis C virus. J Hepatol 1992;15:382-386.
2. Bronowicki JP, Loriot M, Thiers V, Grignon Y, Zignego AL, Bréchot C. Hepatitis C virus persistence in human hematopoietic cells injected into SCID mice. HEPATOLOGY 1998;28:211-218.
3. Misiani R, Bellavita P, Fenili D, Borelli G, Marchesi D, Massazza M, Vendramen G, et al. Hepatitis C virus infection in patients with essential mixed cryoglobulinemia. Ann Intern Med 1992;117:573-577.
4. Agnello V, Chung RT, Kaplan LM. A role for hepatitis C virus infection in type II cryoglobulinemia. N Engl J Med 1992;327:1490-1495.
5. Pawlotsky JM, Roudot-Thoraval F, Simmonds P, Mellor J, Ben Yahia MB, Andre C, Voisin MC, et al. Extrahepatic immunologic manifestations in chronic hepatitis C and hepatitis C virus serotypes. Ann Intern Med 1995;122:169-173.
6. Monteverde A, Rivano MT, Allegra GC, Monteverde AI, Zigrossi P, Baglioni P, Gobbi M, et al. Essential mixed cryoglobulinemia, type II: a manifestation of a low-grade malignant lymphoma? Clinical-morphological study of 12 cases with special reference to immunohistochemical findings in liver frozen sections. Acta Haematol 1988;79:20-25.
7. Rasul I, Shepherd FA, Kamel-Reid S, Krajden M, Pantalony D, Heathcote EJ. Detection of occult low-grade B-cell non-hodgkin's lymphoma in patients with chronic hepatitis C infection and mixed cryoglobulinemia. HEPATOLOGY 1999;29:543-547.
8. Ferri C, Caracciolo F, Zignego AL, La Civita L, Monti M, Longombardo G, Lombardini F, et al. Hepatitis C virus infection in patients with non-Hodgkin's lymphoma. Br J Haematol 1994;88:392-394.
9. Luppi M, Grazia Ferrari M, Bonaccorsi G, Longo G, Narni F, Barozzi P, Marasca R, et al. Hepatitis C virus infection in subsets of neoplasric lymphoproliferations not associated with cryoglobulinemia. Leukemia 1996;10:351-355.
10. Silvestri F, Pipan C, Barillari G, Zaja F, Fanin R, Infanti L, Russo D, et al. Prevalence of hepatitis C virus infection in patients with lymphoproliferarive disorders. Blood 1996;87:4296-4301.
11. Zuckerman E, Zuckerman T, Levine AM, Douer D, Gurekunst K, Mizokami M, Qian DG, et al. Hepatitis C virus infection in patients with B-cell non-Hodgkin lymphoma. Ann Intern Med 1997;127:423-428.
12. McColl MD, Tait RC. Hepatitis C virus infection in patients with lymphoproliferative disorders. Br J Haematol 1996;92:771-773.
13. Brind AM, Watson JP, Burt A, Kestevan P, Wallis J, Proctor SJ, Bassendine MF. Non-Hodgkin's lymphoma and hepatitis C virus infection. Leuk Lymphoma 1996;21:127-130.
14. King PD, Wilkes JD, Diaz-Arias AA. Hepatitis C virus infection in nonHodgkin's lymphoma. Clin Lab Haematol 1998;20:107-110.
15. Collier JD, Zanke B, Moore M, Kessler G, Krajden M, Shepherd F, Heathcote J. No association between hepatitis C and B-cell lymphoma. HEPATOLOGY 1999;29:1259-1261.
16. Zafrani ES, Gaulard P. Primary lymphoma of the liver. Liver 1993;13:5761.
17. Lei KIK. Primary non-Hodgkin's lymphoma of the liver. Leuk Lymphoma 1998;29:293-299.
18. Ryan J, Wallace S, Jones P, Taggart G, Dudley F. Primary hepatic lymphoma in a patient with chronic hepatitis C. J Gastroenterol Heparol 1994;9:308-310.
19. Morita K, Hoshino H, Imada J, Yoshida N, Nishimura D, Katada N, Sano H, et al. Primary malignant lymphoma of the liver associated with cirrhosis induced by hepatitis C viral infection. Intern Med 1995;34:192-194.
20. Ellenrieder V, Beckh K, Muller D, Klatt S, Adler G. Intrahepatic highgrade malignant non-Hodgkin lymphoma in a patient with chronic hepatitis C infection. Z Gastroenterol 1996;34:283-285.
21. Clarke G, MacMarhuna P, Fenlon H, Callagy G, O'Keane JC, Carney D, Crowe J. Primary hepatic lymphoma in a man with chronic hepatitis C. Eur J Gastroenterol Hepatol 1997;9:87-90.
22. Mohler M, Gutzler F, Kallinowski B, Goeser T, Stremmel W. Primary hepatic high-grade non-Hodgkin's lymphoma and chronic hepatitis C infection. Dig Dis Sci 1997;42:2241-2245.
23. Ohsawa M, Tomita Y, Hashimoto M, Kanno H, Aozasa K. Hepatitis C viral genome in a subset of primary hepatic lymphomas. Mod Pathol 1998;11:471-478.
24. Rubbia-Brandt L, Brundler MA, Kerl K, Negro F, Nador RG, Scherrer A, Kurt AM, et al. Primary hepatic diffuse large B-cell lymphoma in a patient with chronic hepatitis C. Am J Surg Pathol 1999;23:1124-1130.
25. Chowla A, Malhi-Chowla N, Chidambaram A, Surick B. Primary hepatic lymphoma in hepatitis C: case report and review of the literature. Am Surg 1999;65:881-883.
26. Kim JH, Kim HY, Kang I, Kim YB, Park CK, Yoo JY, Kim ST. A case of primary hepatic lymphoma with hepatitis C liver cirrhosis. Am J Gastroenterol 2000;95:2377-2380.
27. Genvresse I, Spath-Schwalbe E, Meisel H, Kaufmann O, Kruger DH, Possinger K. Primary hepatic or splenic diffuse large B-cell lymphoma and hepatitis C virus infection: a non-fortuitous association? Ann Hematol 2000;79:530-532.
28. Caccamo D, Pervez NK, Marchevsky A. Primary lymphoma of the liver in the acquired immunodeficiency syndrome. Arch Pathol Lab Med 1986;110:553-555.
29. Harris NL, Jaffe ES, Diebold J, Flandrin G, Muller-Hermelink HK, Vardiman J, Lister TA, et al. The World Health Organization classification of neoplastic diseases of the haematopoietic and lymphoid tissues: Report of the Clinical Advisory Committee Meeting, Airlie House, Virginia, November 1997. Hispopathology 2000;36:69-86.
30. Freeman C, Berg JW, Cutler SJ. Occurrence and prognosis of extranodal lymphomas. Cancer 1972;29:252-260.
31. Lei KI, Chow JH, Johnson PJ. Aggressive primary hepatic lymphoma in Chinese patients. Presentation, pathologic features, and outcome. Cancer 1995;76:1336-1343.
32. Page RD, Romaguera JE, Osborne B, Medeiros LJ, Rodriguez J, North L, Sanz-Rodriguez C, et al. Primary hepatic lymphoma. Cancer 2001;92:2023-2029.
33. Emile JF, Azoulay D, Gornet JM, Lopes G, Delvart V, Samuel D, Reynes M, et al. Primary non-Hodgkin's lymphomas of the liver with nodular and diffuse infiltration patterns have different prognoses. Ann Oncol 2001;12:1005-1010.
34. Dubois F, Desenclos JC, Mariotte N, Goudeau A. Hepatitis C in a French population-based survey, 1994: seroprevalence, frequency of viremia, genotype distribution, and risk factors. The Collaborative Study Group. HEPATOLOGY 1997;25:1490-1496.
35. Pradat P, Caillat-Vallet E, Sahajian F, Bailly F, Excler G, Sepetjan M, Trepo C, et al. Prevalence of hepatitis C infection among general practice patients in the Lyon area, France. Eur J Epidemiol 2001;17:47-51.
36. Germanidis G, Haioun C, Pourquier J, Gaulard P, Pawlotsky JM, Dhumeaux D, Reyes F. Hepatitis C virus infection in patients with overt B-cell non-Hodgkin's lymphoma in a French center. Blood 1999;93:1778-1779.
37. Bauduer F, Katsahian S, Blanchard Y, Oui B, Capdupuy C, Renoux M. Descriptive epidemiology of non-Hodgkin lymphomas in a southwestern French hematology center: absence ofsignificant relationship with hepatitis C virus infection. Hematol Cell Ther 1999;41:191-193.
38. Hausfater P, Cacoub P, Rosenthal E, Bernard N, Loustaud-Ratti V, Le Lostec, Laurichesse H, et al. Hepatitis C virus infection and lymphoproliferative diseases in France: a national study. The GERMIVIC Group. Am J Hematol 2000;64:107-111.
39. De Vita S, Sacco C, Sansonno D, Gloghini A, Dammacco F, Crovatto M, Santini G, et al. Characterization of overt B-cell lymphomas in patients with hepatitis C virus infection. Blood 1997;90:776-782.
40. De Rosa G, Gobbo ML, De Renzo A, Notaro R, Garofalo S, Grimaldi M, Apuzzo A, et al. High prevalence of hepatitis C virus infection in patients with B-cell lymphoproliferative disorders in Italy. Am J Hematol 1997;55:77-82.
41. Silvestri F, Barillari G, Fanin R, Pipan C, Falasca E, Salmaso F, Zaja F, et al. Hepatitis C virus infection among cryoglobulinemic and non-cryoglobulinemic B-cell non-Hodgkin's lymphomas. Haematologica 1997;82:314-317.
42. Zignego AL, Giannelli F, Marrocchi ME, Mazzocca A, Ferri C, Giannini C, Monti M, et al. T(14;18) translocation in chronic hepatitis C virus infection. HEPATOLOGY 2000;31:474-479.
43. Zuckerman E, Zuckerman T, Sahar D, Streichman S, Attias D, Sabo E, Yeshurun D, et al. Bcl-2 and immunoglobulin gene rearrangement in patients with hepatitis C virus infection. Br J Haematol 2001;112:364369.
44. Zuckerman E, Zuckerman T, Sahar D, Streichman S, Attias D, Sabo E, Yeshurun D, et al. The effect of antiviral therapy on (14;18) translocation and immunoglobulin gene rearrangement in patients with chronic hepatitis C virus infection. Blood 2001;97:1555-1559.
45. Ray RB, Lagging LM, Meyer K, Ray R. Hepatitis C virus core protein cooperates with ras and transforms primary rat embryo fibroblasts to tumorigenic phenotype. J Virol 1996;70:4438-4443.
46. Ghosh AK, Steele R, Meyer K, Ray R, Ray RB. Hepatitis C virus NS5A protein modulates cell cycle regulatory genes and promotes cell growth. J Gen Virol 1999;80:1179-1183.
47. Sansonno D, De Vita S, Cornacchiulo V, Carbone A, Boiocchi M, Dammacco F. Detection and distribution of hepatitis C virus-related proteins in lymph nodes ofpatients with type II mixed cryoglobulinemia and neoplastic or non-neoplastic lymphoproliferation. Blood 1996;88:4638-4645.